Condensed Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating expenses
Research and development	$ 32,222	$ 23,786	$ 90,596	$ 63,221
General and administrative	8,210	5,666	22,696	17,274
Total operating expenses	40,432	29,452	113,292	80,495
Loss from operations	(40,432)	(29,452)	(113,292)	(80,495)
Other income
Interest income	6,303	3,739	19,141	10,475
Total other income	6,303	3,739	19,141	10,475
Net loss	(34,129)	(25,713)	(94,151)	(70,020)
Other comprehensive income (loss):
Unrealized gain on available-for-sale securities	2,105	123	952	931
Total comprehensive loss	$ (32,024)	$ (25,590)	$ (93,199)	$ (69,089)
Net loss per share, basic (in dollars per share)	$ (0.36)	$ (0.41)	$ (1.03)	$ (1.10)
Net loss per share, diluted (in dollars per share)	$ (0.36)	$ (0.41)	$ (1.03)	$ (1.10)
Weighted-average shares outstanding, basic	93,813,346	63,459,560	91,639,964	63,369,358
Weighted-average shares outstanding, diluted	93,813,346	63,459,560	91,639,964	63,369,358